MX2022014634A - Metodos para la administracion linfatica de agentes activos. - Google Patents

Metodos para la administracion linfatica de agentes activos.

Info

Publication number
MX2022014634A
MX2022014634A MX2022014634A MX2022014634A MX2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A MX 2022014634 A MX2022014634 A MX 2022014634A
Authority
MX
Mexico
Prior art keywords
methods
active agents
lymphatic delivery
agents
delivery
Prior art date
Application number
MX2022014634A
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Publication of MX2022014634A publication Critical patent/MX2022014634A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Cosmetics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a la administración de agentes a la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para administrar un agente a una o más áreas de la epidermis y, de esta manera, al sistema linfático.
MX2022014634A 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos. MX2022014634A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562196558P 2015-07-24 2015-07-24
US201562196568P 2015-07-24 2015-07-24

Publications (1)

Publication Number Publication Date
MX2022014634A true MX2022014634A (es) 2023-01-18

Family

ID=57885089

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000126A MX2018000126A (es) 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos.
MX2022014634A MX2022014634A (es) 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018000126A MX2018000126A (es) 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos.

Country Status (14)

Country Link
US (3) US10737082B2 (es)
EP (2) EP3325081B1 (es)
JP (3) JP6929829B2 (es)
KR (1) KR20180035210A (es)
AU (3) AU2016297832B2 (es)
BR (1) BR112018001435A2 (es)
CA (1) CA2991459A1 (es)
DK (1) DK3325081T3 (es)
ES (1) ES2893673T3 (es)
HU (1) HUE056424T2 (es)
MX (2) MX2018000126A (es)
PL (1) PL3325081T3 (es)
RU (1) RU2719946C2 (es)
WO (1) WO2017019535A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017019526A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for better delivery of active agents to tumors
BR112018001435A2 (pt) * 2015-07-24 2018-09-11 Kimberly Clark Co métodos para entrega linfática de agentes ativos
JP7182794B2 (ja) * 2017-08-31 2022-12-05 国立大学法人東北大学 リンパ行性薬剤送達法に有効な薬剤を含む溶液の適正な浸透圧域
CN115038463A (zh) 2019-12-05 2022-09-09 索伦托药业有限公司 通过淋巴递送装置施用抗pd-1或抗pd-l1治疗剂以治疗癌症的方法
CN117813128A (zh) 2021-01-22 2024-04-02 索伦托药业有限公司 用于微升级淋巴递送冠状病毒疫苗的装置
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CA3221925A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
CA3228858A1 (en) 2021-08-18 2023-02-23 Russell F. Ross Therapeutic agents targeting the lymphatic system

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US20020095134A1 (en) 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
IL147640A0 (en) * 2000-06-01 2002-08-14 Watson Pharmaceuticals Inc Transdermal delivery of lasofoxifene
JP2006516006A (ja) 2003-01-16 2006-06-15 ベクトン・ディキンソン・アンド・カンパニー 細ゲージのマイクロカニューレを用いる皮内細胞の送達
CA2529048A1 (en) * 2003-06-13 2005-02-24 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
US20050180952A1 (en) 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
CA2618807C (en) 2005-08-12 2015-01-06 University Health Network Methods and devices for lymphatic targeting
WO2007047539A2 (en) 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
WO2008038140A2 (en) 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
US8798932B2 (en) * 2008-10-31 2014-08-05 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
WO2011135532A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. Composite microneedle array including nanostructures thereon
MX2012012567A (es) * 2010-04-28 2012-11-21 Kimberly Clark Co Metodo para aumentar la permeabilidad de una barrera epitelial.
EP2563450B1 (en) 2010-04-28 2017-07-26 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
KR101794376B1 (ko) 2010-04-28 2017-11-06 킴벌리-클라크 월드와이드, 인크. ｓｉＲＮＡ 전달용 의료 기구
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
ES2764105T3 (es) * 2011-10-17 2020-06-02 Massachusetts Inst Technology Administración intracelular
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
EP3574950B1 (en) * 2011-10-27 2021-02-17 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
US9944019B2 (en) * 2012-05-01 2018-04-17 University of Pittsburgh—of the Commonwealth System of Higher Education Tip-loaded microneedle arrays for transdermal insertion
CN109621083B (zh) 2013-02-28 2022-03-22 索伦托治疗有限公司 药物递送装置
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
AU2014270014A1 (en) 2013-05-23 2015-12-17 Kimberly-Clark Worldwide, Inc. Microneedles with improved open channel cross-sectional geometries
BR112018001435A2 (pt) * 2015-07-24 2018-09-11 Kimberly Clark Co métodos para entrega linfática de agentes ativos
WO2017019526A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for better delivery of active agents to tumors

Also Published As

Publication number Publication date
JP6929829B2 (ja) 2021-09-01
EP3922238A1 (en) 2021-12-15
JP2021185160A (ja) 2021-12-09
CN107949418A (zh) 2018-04-20
US10737082B2 (en) 2020-08-11
CA2991459A1 (en) 2017-02-02
RU2719946C2 (ru) 2020-04-23
KR20180035210A (ko) 2018-04-05
AU2016297832A1 (en) 2018-02-15
AU2020233748A1 (en) 2020-10-08
EP3325081A4 (en) 2019-04-10
AU2016297832B2 (en) 2020-07-16
JP2023015135A (ja) 2023-01-31
US20180193625A1 (en) 2018-07-12
US20240181235A1 (en) 2024-06-06
DK3325081T3 (da) 2021-10-11
EP3325081A2 (en) 2018-05-30
JP2018522002A (ja) 2018-08-09
RU2018104104A3 (es) 2019-10-31
HUE056424T2 (hu) 2022-02-28
BR112018001435A2 (pt) 2018-09-11
US20200338329A1 (en) 2020-10-29
AU2020233748B2 (en) 2022-08-25
ES2893673T3 (es) 2022-02-09
RU2018104104A (ru) 2019-08-26
EP3325081B1 (en) 2021-09-08
WO2017019535A2 (en) 2017-02-02
MX2018000126A (es) 2018-03-23
AU2022275393A1 (en) 2023-01-05
PL3325081T3 (pl) 2021-12-20
JP7167272B2 (ja) 2022-11-08

Similar Documents

Publication Publication Date Title
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
MX2022014277A (es) Metodos para una mejor administracion de agentes activos a tumores.
PH12017500070A1 (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
MX2018012486A (es) Composiciones para aplicacion topica de compuestos.
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
PH12016500871A1 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
GB2541571A (en) Pharmaceutical compositions
MY195009A (en) Cellular Targeted Active Ingredient Delivery System
MX2021000773A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos de uso del mismo.
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
PH12016501527B1 (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2018005035A (es) Formulaciones de liberacion sostenida de anestesicos locales.
MX2022011564A (es) Tratamiento del dolor.
MX2017009608A (es) Compuestos anticancerigenos.
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2017013879A (es) Composiciones que comprenden anakinra.
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis